12

Synbio Tech Inc.

1295 · TWO · Healthcare / Biotechnology

42.10TWD+0.10 (+0.24%)

Price History

Full chart

Market Stats

Previous Close42.00
Open41.60
Day Range41.60 – 42.50
52-Week Range44.05 – 118.13
Volume26.25K
Market Cap1.83B
P/E (TTM)11.38
Forward P/E0.00
EPS4.28
Dividend Yield6.26%
Beta0.52
50-Day Avg46.10
200-Day Avg60.47

About

Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional strain includes SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improve digestive and promote human health; SynForU-ImmuUp for immune system; SynForU-GastroKeep, a stomach care probiotic; SynForU-HepaAid, a liver care probiotic; SynForU-HerCare, which inhibits the growth of fungal and bacterial pathogens, as well as maintains the vaginal microbiome in proper balance; multi strain probiotics; and postbiotics, which include LDL557, for modulate the immune system, reduce inflammation and joint pain, and M1, to support immune system. In addition, it offers GABAbiotics-Adaptogenic Postbiotics, Synbio-Oligo, and Yogurt Powder for food applications; pet health solutions, including SYNPET functional probiotics, SYNPET GO for muscle and joint care, SYNPET IMMU for skin and immunity care, SYNPET FIT for weight management, and SYNPET TRENAL for kidney health care and functional prebiotics. Further, the company provides SYNFERM Pigment, a lactobacillus strains that rapidly produce lactic acid; SYNFERM Feed for digestion and rapid nutrient uptake in poultry and livestock; and SYNFERM Corn Silage for ruminant animals with high digestible nutrients. Additionally, it offers SYNSEA FeedAd, a probiotic complex for aquatic livestock; and SYNSEA Clean EX for reduction in the concentrations of nitrites and ammonia in water, as well as antibiotic-free probiotic solutions for poultry, swine, aquaculture, ruminant, and pigmented plants. The company was incorporated in 2000 and is based in Kaohsiung, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOSan-Lian Yang
  • HeadquartersNo. 66, Beiling 6th Road, Kaohsiung, Taiwan, 821, Taiwan
  • Websitehttps://www.synbiotech.com

Leadership

  • San-Lian YangGM & Director
  • Hsiu-Ju ChangAccounting Supervisor
  • Chuan-Xian YangGM & Corporate Director Representative
  • Kui-Ming LiDeputy General Manager
  • Mr. Jin-Sheng LinDeputy General Manager
  • Yi-Ru ZhangDeputy General Manager

Financials

Income Statement

Currency: TWD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue737.45M855.79M739.33M823.30M989.48M1.04B
Growth (%)-+16.05%-13.61%+11.36%+20.18%+4.97%
Cost of Revenue347.56M409.61M378.00M404.56M448.64M483.47M
Gross Profit389.89M446.18M361.33M418.75M540.84M555.20M
Gross Margin52.87%52.14%48.87%50.86%54.66%53.45%
Operating Expense231.32M259.65M259.49M275.79M331.45M356.79M
Operating Income158.56M186.53M101.83M142.96M209.40M198.41M
Operating Margin21.50%21.80%13.77%17.36%21.16%19.10%
EBITDA237.03M267.96M200.66M230.54M316.35M294.30M
EBITDA Margin32.14%31.31%27.14%28.00%31.97%28.33%
Net Income131.80M159.97M92.52M113.27M170.13M175.97M
Net Income Margin17.87%18.69%12.51%13.76%17.19%16.94%
R&D81.07M84.29M83.46M82.66M108.57M118.84M
R&D as % of Total Revenue10.99%9.85%11.29%10.04%10.97%11.44%
Interest Expense10.59M7.84M7.69M6.59M3.71M12.70M
Interest Expense % of Total Revenue1.44%0.92%1.04%0.80%0.38%1.22%

Balance Sheet

Currency: TWD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.39B1.53B1.68B1.89B2.34B3.09B
Total Liabilities626.89M669.93M779.07M943.27M1.27B1.76B
Total Equity758.45M863.17M897.68M942.97M1.08B1.33B
Cash65.13M184.61M226.28M346.74M469.39M269.94M
Total Debt450.11M506.37M628.79M731.77M953.81M-
Net Debt384.98M321.76M402.50M385.03M484.42M980.67M

Cash Flow

Currency: TWD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow211.52M262.88M187.09M213.93M261.54M143.35M
Investing Cash Flow-84.79M-101.52M-203.43M-137.17M-313.21M-
Financing Cash Flow-124.85M-35.73M59.80M49.16M166.03M-
Capital Expenditure11.08M44.61M220.27M327.70M310.95M705.01M
Free Cash Flow200.44M218.26M-33.18M-113.77M-49.41M-561.66M
Dividends Paid-60.42M70.15M61.48M46.11M109.74M
FCF to OCF94.76%83.03%-17.74%-53.18%-18.89%-391.82%
Dividend Paid to FCF-27.68%-211.42%-54.04%-93.32%-19.54%

Earnings

Report DateAug 12, 2025Nov 11, 2025
EPS Estimate1.641.91
EPS Actual1.910.92
Surprise16.46%-51.83%
TimingPre-marketPre-market

Key Statistics & Ratios

Market Cap1.83B
Enterprise Value2.85B
Trailing P/E11.38
Forward P/E0.00
Price / Sales1.82
Price / Book1.30
EPS4.28
Book Value38.02
Revenue (TTM)1.01B
Gross Profit (TTM)503.48M
EBITDA240.20M
Profit Margin14.11%
Operating Margin20.86%
Return on Equity11.21%
Return on Assets2.72%
Shares Outstanding37.60M
Shares Float13.48M
Beta0.52
Dividend Yield6.26%
Dividend Rate2.99
Payout Ratio3.25%

Dividends

20261×
2.99Mar 27, 2026
20251×
3.49Mar 27, 2025
20241×
1.47Jun 27, 2024

Stock Splits

  • Aug 6, 20241020:1000